Sepsis Treatment Market

Industry Overview

The Global Sepsis Treatment Market is expected to grow from USD 0.46 billion in 2023 to USD 0.86 billion in 2030 at a CAGR of 8.8% during the forecast period ranging from 2025 to 2030.

Sepsis is a life-threatening disease. It is caused when a specific chemical develops in the immune system and spreads into the bloodstream. The treatment includes a wide range of medical procedures and technological solutions. These help in the diagnosis of sepsis, its management and treatment. Solutions include medications and supportive care measures after proper diagnostics using different medical equipment. 

A high prevalence of this disease increases the demand for effective diagnostic solutions, which is expected to drive market growth. The rising aging population who are vulnerable to this disease due to their weaker immune system also fuels the growth of the sepsis treatment industry. Furthermore, the mandate for antibiotic-resistant bacterial strains, growing incidents of hospital-acquired infections, and the high prevalence of a wide range of chronic diseases such as diabetes may also contribute to the growth of the sepsis treatment market.

The growth of the market is somewhat hindered due to low healthcare spending among the low-income and middle-income groups. Also, the advent of a generic industry and a significant lack of public interest slows down the market growth significantly. However, laboratory and blood transfusion centers are using more innovative and effective culture-based procedures. This helps physicians to detect infected platelets donated and reduce the risk of sepsis. This creates new growth opportunities.

Market Segmentation

Insight by Technology

The Global Sepsis Treatment Market is divided by technology into blood culture, immunoassays, flow cytometry, microfluidics, biomarkers, and molecular diagnostics segments. The molecular diagnostics segment is further divided into PCR, peptide nucleic acid-fluorescent in situ hybridization, microarrays, and syndromic panel-based testing subsegments. Out of all these major segments, the blood culture segment will account for the larger share due to higher adoption and low-cost microbiology procedures.

Insight by Product

The Global Sepsis Treatment Market is divided by product into Blood Culture Media, Assays & Reagents, Instruments, and Software segments. Among all of them, the software segment is expected to grow at a higher CAGR due to the rise in the adoption of advanced technological systems by healthcare providers for better sepsis diagnosis and treatment.

Insight by Pathogen

The Global Sepsis Treatment Market is divided by pathogen into fungal sepsis, bacterial sepsis, and other segments, where the bacterial sepsis segment is further divided into gram-negative bacterial sepsis and gram-positive bacterial sepsis subsegments. Among these segments, the gram-negative bacteria segment is expected to dominate during the projected period due to the high prevalence and patient affliction. It is also attributed to the rise in R&D initiatives and growing regulatory acceptance of innovative solutions.

Insight by Test Type

The Global Sepsis Treatment Market is divided by test type into laboratory tests and point-of-care test segments. Out of these segments, the laboratory testing segment is expected to have the largest market share due to higher accuracy than POC testing, comprehensive examination of the pathogen, and higher drug resistance profile.

Insight by End User

The Global Sepsis Treatment Market is divided by end users into hospitals, pathology & reference laboratories, research laboratories & academic institutes, out of which the hospital end-user segment will account for the largest share of the sepsis treatment market. It is mainly attributed to the high prevalence of sepsis, the large number of fatalities caused, and a large number of blood culture tests performed in the in-house hospital laboratories to identify BSIs.

Global Sepsis Treatment Market Report Coverage

Industry Trends

The most notable trends within the industry are the growing regulatory acceptance and the launch of technically innovative diagnostic solutions. In addition, the early recognition and management of sepsis have grown in importance. This is mainly because prompt intervention is vital for sepsis treatment to improve patient outcomes. This is usually done by administering antibiotics to alleviate infection and providing supportive care to improve the condition of the patient.

Growth Drivers

The most significant growth driver of the sepsis market is the growing awareness among people about early diagnosis and treatment. In addition, the technological advancements in the medical sector and the presence of a large number of pharmaceutical companies are propelling market growth. There are also a significant number of emerging players stepping into the market with their innovative treatment approaches, raising competition and growth prospects. Continual research and development initiatives to develop novel therapies for targeted treatments, such as immunomodulatory therapies, anti-inflammatory agents, and adjunctive therapies and precision medicine, are driving the sepsis market. Also, Point-of-care testing (POCT) technology and quick diagnostic tools that reduce waiting times, growing attention to innovative medicines with higher efficiency and lower side effects, and the adoption of personalized precision medicine for a more individualized approach to treatment are fueling the market growth.

Challenges

One of the most significant growth hindrances is the unfavorable insurance plans. In addition, the high cost involved in such care, along with a lot of product withdrawals due to inferior efficacy, also restricts the development of the sepsis market.

Opportunities

A large number of groundbreaking tests for early detection and cost-effective solutions are creating new growth opportunities for the market players. These procedures typically analyze the patient's blood with a microelectrode that produces accurate results in quick time. Also, other technical developments in the existing processes to create newer and better solutions offer significant growth opportunities.

Geographic Overview

North America will account for the largest share of the global sepsis market due to a well-established medical device industry and healthcare infrastructure. It is also attributed to the widespread adoption of advanced sepsis diagnostic technology by several medical practitioners and the growth in the number of sepsis incidences in the region. Technical developments in the field also contribute to the high demand and growth of the market.

The Asia-Pacific market is expected to grow during the forecast period as well due to the growing geriatric population and the increasing prevalence of cancer and diabetes cases in countries like India, China, and Australia. In addition, the developing healthcare infrastructure in this region also propels market growth.

Market Players

•    Abbott
•    Pfizer Inc
•    GlaxoSmithKline plc
•    Bristol-Myers Squibb Company
•    Adrenomed AG
•    AM-Pharma B.V.
•    Johnson & Johnson
•    Amomed Pharma GmbH
•    Asahi Kasei Corporation
•    Endacea, Inc
•    Novartis
•    TEVA
•    INOTREM
•    InflaRx N.V.
•    Bayer
•    Shanghai Pharmaceuticals
•    La Jolla Pharmaceutical Company
•    TaiRx, Inc. 

GSK plc is a British multinational pharmaceutical and biotechnology company with global headquarters in London. It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm.

Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Green Oaks, Illinois, United States. 

Recent Developments by Key Players

Inotrem (an advanced clinical stage biotech company specializing in immunotherapies for acute and chronic inflammatory syndromes) has announced the outcome of its regulatory interactions with the US Food and Drug Administration (FDA) to finalize the design of a single Phase 3 registration trial (ACCURATE) for nangibotide in septic shock. 

The Sepsis Treatment Market report offers a comprehensive market segmentation analysis along with an estimation for the forecast period 2025–2030.

Segments Covered in the Report

• By Technology
  • Blood Culture
  • Immunoassays
  • Molecular Diagnostics
  • Flow Cytometry
  • Microfluidics
  • Biomarkers
• By Product 
  • Blood Culture Media
  • Assays & Reagents
  • Instruments
  • Software
• By Pathogen
  • Bacterial Sepsis
  • Fungal Sepsis
  • Other Pathogen
• By Test Type
  • Laboratory Tests
  • Point-of-Care Tests
• By End-User
  • Hospitals
  • Pathology & Reference Laboratories
  • Research Laboratories & Academic Institutes

Region Covered in the Report

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia-Pacific (APAC)
  • China
  • Japan
  • India
  • South Korea
  • Rest of Asia-Pacific
• Rest of the World (RoW)
  • Brazil
  • Saudi Arabia
  • South Africa
  • U.A.E.
  • Other Countries

Source: VynZ Research

Source: VynZ Research

1.    Research Overview

        1.1.    The Report Offers
        1.2.    Market Coverage
                1.2.1.    By Technology
                1.2.2.    By Product
                1.2.3.    By Pathogen
                1.2.4.    By Pathogen
                1.2.5.    By Test Type
                1.2.6.    By End-User
        1.3.    Research Phases
        1.4.    Limitations
        1.5.    Research Methodology
                1.5.1.    Data Sources
                        1.5.1.1.    Primary Research
                        1.5.1.2.    Secondary Research
                1.5.2.    Methodology
                        1.5.2.1.    Data Exploration
                        1.5.2.2.    Forecast Parameters
                        1.5.2.3.    Data Validation
                        1.5.2.4.    Assumptions
                1.5.3.    Study Period & Data Reporting Unit

2.    Executive Summary

3.    Industry Overview

        3.1.    Industry Dynamics
                3.1.1.    Market Growth Drivers
                3.1.2.    Market Restraints
                3.1.3.    Key Market Trends
                3.1.4.    Major Opportunities
        3.2.    Industry Ecosystem
                3.2.1.    Porter’s Five Forces Analysis
                3.2.2.    Recent Development Analysis
                3.2.3.    Value Chain Analysis
        3.3.    Competitive Insight
                3.3.1.    Competitive Position of Industry Players
                3.3.2.    Market Attractive Analysis

4.    Global Market Estimate and Forecast

        4.1.    Global Market Overview
        4.2.    Global Market Estimate and Forecast to 2030

5.    Market Segmentation Estimate and Forecast

        5.1.    By Technology
                5.1.1.    Blood Culture
                        5.1.1.1.    Market Definition
                        5.1.1.2.    Market Estimation and Forecast to 2030
                5.1.2.    Immunoassays
                        5.1.2.1.    Market Definition
                        5.1.2.2.    Market Estimation and Forecast to 2030
            5.1.3.    Molecular Diagnostic
                        5.1.3.1.    Market Definition
                        5.1.3.2.    Market Estimation and Forecast to 2030
            5.1.4.    Flow Cytometry
                        5.1.4.1.    Market Definition
                        5.1.4.2.    Market Estimation and Forecast to 2030
            5.1.5.    Microfluidics
                        5.1.5.1.    Market Definition
                        5.1.5.2.    Market Estimation and Forecast to 2030
            5.1.6.    Biomarkers
                        5.1.6.1.    Market Definition
                        5.1.6.2.    Market Estimation and Forecast to 2030
        5.2.    By Product
                5.2.1.    Blood Culture Media
                        5.2.1.1.    Market Definition
                        5.2.1.2.    Market Estimation and Forecast to 2030
                5.2.2.    Assays & Reagents
                        5.2.2.1.    Market Definition
                        5.2.2.2.    Market Estimation and Forecast to 2030
                5.2.3.    Instruments
                        5.2.3.1.    Market Definition
                        5.2.3.2.    Market Estimation and Forecast to 2030
                5.2.4.    Software
                        5.2.4.1.    Market Definition
                        5.2.4.2.    Market Estimation and Forecast to 2030               
        5.3.    By Pathogen 
                5.3.1.    Bacterial Sepsis
                        5.3.1.1.    Market Definition
                        5.3.1.2.    Market Estimation and Forecast to 2030
                5.3.2.    Fungal Sepsis 
                        5.3.2.1.    Market Definition
                        5.3.2.2.    Market Estimation and Forecast to 2030
                5.3.3.    Other Pathogen
                        5.3.3.1.    Market Definition
                        5.3.3.2.    Market Estimation and Forecast to 2030
        5.4.    By Test Type
                5.4.1.    Laboratory
                        5.4.1.1.    Market Definition
                        5.4.1.2.    Market Estimation and Forecast to 2030
                5.4.2.    Point-of-Care Test 
                        5.4.2.1.    Market Definition
                        5.4.2.2.    Market Estimation and Forecast to 2030
        5.5.    By End User  
                5.5.1.    Hospitals
                        5.5.1.1.    Market Definition
                        5.5.1.2.    Market Estimation and Forecast to 2030
                5.5.2.    Pathology & Reference Laboratories  
                        5.5.2.1.    Market Definition
                        5.5.2.2.    Market Estimation and Forecast to 2030
                5.5.3.    Research Laboratories & Academic Institutes
                        5.5.3.1.    Market Definition
                        5.5.3.2.    Market Estimation and Forecast to 2030
        5.6.    By Region
                5.6.1.    North America
                        5.6.1.1.    Market Definition
                        5.6.1.2.    Market Estimation and Forecast to 2030
                5.6.2.    Europe
                        5.6.2.1.    Market Definition
                        5.6.2.2.    Market Estimation and Forecast to 2030
                5.6.3.    Asia Pacific
                        5.6.3.1.    Market Definition
                        5.6.3.2.    Market Estimation and Forecast to 2030
                5.6.4.    Rest of the World
                        5.6.4.1.    Market Definition
                        5.6.4.2.    Market Estimation and Forecast to 2030

6.    North America Market Estimate and Forecast

        6.1.    By Technology
        6.2.    By Product
        6.3.    By Pathogen
        6.4.    By Test Type
        6.5.    End-User 
        6.6.    By Country
                6.6.1.    U.S. Market Estimate and Forecast
                6.6.2.    Canada Market Estimate and Forecast
                6.6.3.    Mexico Market Estimate and Forecast

7.    Europe Market Estimate and Forecast

        7.1.    By Technology
        7.2.    By Product
        7.3.    By Pathogen
        7.4.    By Test Type
        7.5.    By End User
        7.6.    By Country
                7.6.1.    Germany Market Estimate and Forecast
                7.6.2.    France Market Estimate and Forecast
                7.6.3.    U.K. Market Estimate and Forecast
                7.6.4.    Italy Market Estimate and Forecast
                7.6.5.    Spain Market Estimate and Forecast
                7.6.6.    Russia Market Estimate and Forecast
                7.6.7.    Rest of Europe Market Estimate and Forecast

8.    Asia-Pacific Market Estimate and Forecast

        8.1.    By Technology
        8.2.    By Product
        8.3.    By Pathogen
        8.4.    By Test Type
        8.5.    By End User
        8.6.    By Country
                8.6.1.    China Market Estimate and Forecast
                8.6.2.    Japan Market Estimate and Forecast
                8.6.3.    India Market Estimate and Forecast
                8.6.4.    South Korea Market Estimate and Forecast
                8.6.5.    Rest of Asia-Pacific Market Estimate and Forecast

9.    Rest of the World (RoW) Market Estimate and Forecast

        9.1.    By Technology
        9.2.    By Product
        9.3.    By Pathogen
        9.4.    By Test Type
        9.5.    By End User
        9.6.    By Country
                9.6.1.    Brazil Market Estimate and Forecast
                9.6.2.    Saudi Arabia Market Estimate and Forecast
                9.6.3.    South Africa Market Estimate and Forecast
                9.6.4.    U.A.E. Market Estimate and Forecast
                9.6.5.    Other Countries Market Estimate and Forecast

10.    Company Profiles

        10.1.    Abbott 
                10.1.1.    Snapshot
                10.1.2.    Overview
                10.1.3.    Offerings
                10.1.4.    Financial Insight
                10.1.5.    Recent Developments
        10.2.    Pfizer Inc 
                10.2.1.    Snapshot
                10.2.2.    Overview
                10.2.3.    Offerings
                10.2.4.    Financial Insight
                10.2.5.    Recent Developments
        10.3.    GlaxoSmithKline plc
                10.3.1.    Snapshot
                10.3.2.    Overview
                10.3.3.    Offerings
                10.3.4.    Financial Insight
                10.3.5.    Recent Developments
        10.4.    Bristol-Myers Squibb Company
                10.4.1.    Snapshot
                10.4.2.    Overview
                10.4.3.    Offerings
                10.4.4.    Financial Insight
                10.4.5.    Recent Developments
        10.5.    Adrenomed AG
                10.5.1.    Snapshot
                10.5.2.    Overview
                10.5.3.    Offerings
                10.5.4.    Financial Insight
                10.5.5.    Recent Developments
        10.6.    AM-Pharma B.V.
                10.6.1.    Snapshot
                10.6.2.    Overview
                10.6.3.    Offerings
                10.6.4.    Financial Insight
                10.6.5.    Recent Developments
        10.7.    Johnson & Johnson
                10.7.1.    Snapshot
                10.7.2.    Overview
                10.7.3.    Offerings
                10.7.4.    Financial Insight
                10.7.5.    Recent Developments
        10.8.    Amomed Pharma GmbH
                10.8.1.    Snapshot
                10.8.2.    Overview
                10.8.3.    Offerings
                10.8.4.    Financial Insight
                10.8.5.    Recent Developments
        10.9.    Asahi Kasei Corporation
                10.9.1.    Snapshot
                10.9.2.    Overview
                10.9.3.    Offerings
                10.9.4.    Financial Insight
                10.9.5.    Recent Developments
        10.10.    Endacea, Inc
                10.10.1.    Snapshot
                10.10.2.    Overview
                10.10.3.    Offerings
                10.10.4.    Financial Insight
                10.10.5.    Recent Developments
        10.11.    Novartis 
                10.11.1.    Snapshot
                10.11.2.    Overview
                10.11.3.    Offerings
                10.11.4.    Financial Insight
                10.11.5.    Recent Developments
        10.12.    TEVA 
                10.12.1.    Snapshot
                10.12.2.    Overview
                10.12.3.    Offerings
                10.12.4.    Financial Insight
                10.12.5.    Recent Developments
        10.13.    INOTREM
                10.13.1.    Snapshot
                10.13.2.    Overview
                10.13.3.    Offerings
                10.13.4.    Financial Insight
                10.13.5.    Recent Developments
        10.14.    InflaRx N.V.
                10.14.1.    Snapshot
                10.14.2.    Overview
                10.14.3.    Offerings
                10.14.4.    Financial Insight
                10.14.5.    Recent Developments
        10.15.    Bayer
                10.15.1.    Snapshot
                10.15.2.    Overview
                10.15.3.    Offerings
                10.15.4.    Financial Insight
                10.15.5.    Recent Developments
        10.16.    Shanghai Pharmaceuticals
                10.16.1.    Snapshot
                10.16.2.    Overview
                10.16.3.    Offerings
                10.16.4.    Financial Insight
                10.16.5.    Recent Developments
        10.17.    La Jolla Pharmaceutical Company
                10.17.1.    Snapshot
                10.17.2.    Overview
                10.17.3.    Offerings
                10.17.4.    Financial Insight
                10.17.5.    Recent Developments
        10.18.    TaiRx, Inc.
                10.18.1.    Snapshot
                10.18.2.    Overview
                10.18.3.    Offerings
                10.18.4.    Financial Insight
                10.18.5.    Recent Developments

11.    Appendix

        11.1.    Exchange Rates
        11.2.    Abbreviations

List of Tables

Table 1 Sources
Table 2 Study Periods
Table 3 Data Reporting Unit
Table 4 Global Sepsis Treatment Market Size, by Technology Type, 2018 - 2023 (USD Billion)
Table 5 Global Sepsis Treatment Market Size, by Technology Type, 2025 - 2030 (USD Billion)
Table 6 Global Sepsis Treatment Market Size, by Product Type, 2018 - 2023 (USD Billion)
Table 7 Global Sepsis Treatment Market Size, by Product Type, 2025 - 2030 (USD Billion)
Table 8 Global Sepsis Treatment Market Size, by Pathogen Type, 2018 - 2023 (USD Billion)
Table 9 Global Sepsis Treatment Market Size, by Pathogen Type, 2025 - 2030 (USD Billion)
Table 10 Global Sepsis Treatment Market Size, by Test Type, 2018 - 2023 (USD Billion)
Table 11 Global Sepsis Treatment Market Size, by Test Type, 2025 - 2030 (USD Billion)
Table 10 Global Sepsis Treatment Market Size, by End-User Type, 2018 - 2023 (USD Billion)
Table 11 Global Sepsis Treatment Market Size, by End-User Type, 2025 - 2030 (USD Billion)
Table 12 Global Sepsis Treatment Market Size, by Region, 2018 - 2023 (USD Billion)
Table 13 Global Sepsis Treatment Market Size, by Region, 2025 - 2030 (USD Billion)
Table 14 North America Global Sepsis Treatment Market Size, by Technology Type, 2018 - 2023 (USD Billion) Sepsis Treatment
Table 15 North America Global Sepsis Treatment Market Size, by Technology Type, 2025 - 2030 (USD Billion)
Table 16 North America Global Sepsis Treatment Market Size, by Product Type, 2018 - 2023 (USD Billion)
Table 17 North America Global Sepsis Treatment Market Size, by Product Type, 2025 - 2030 (USD Billion)
Table 18 North America Global Sepsis Treatment Market Size, by Pathogen, 2018 - 2023 (USD Billion)
Table 19 North America Global Sepsis Treatment Market Size, by Pathogen, 2025 - 2030 (USD Billion)
Table 20 North America Global Sepsis Treatment Market Size, by Test Type, 2018 - 2023 (USD Billion)
Table 21 North America Global Sepsis Treatment Market Size, by Test Type, 2025 - 2030 (USD Billion)
Table 22 North America Global Sepsis Treatment Market Size, by End User, 2018 - 2023 (USD Billion)
Table 23 North America Global Sepsis Treatment Market Size, by End User, 2025 - 2030 (USD Billion)
Table 24 North America Global Sepsis Treatment Market Size, by Region, 2018 - 2023 (USD Billion)
Table 25 North America Global Sepsis Treatment Market Size, by Region, 2025 - 2030 (USD Billion)
Table 26 Europe Global Sepsis Treatment Market Size, by Technology Type, 2018 - 2023 (USD Billion) Sepsis Treatment
Table 27 Europe Global Sepsis Treatment Market Size, by Technology Type, 2025 - 2030 (USD Billion)
Table 28 Europe Global Sepsis Treatment Market Size, by Product Type, 2018 - 2023 (USD Billion)
Table 29 Europe Global Sepsis Treatment Market Size, by Product Type, 2025 - 2030 (USD Billion)
Table 30 Europe Global Sepsis Treatment Market Size, by Pathogen, 2018 - 2023 (USD Billion)
Table 31 Europe Global Sepsis Treatment Market Size, by Pathogen, 2025 - 2030 (USD Billion)
Table 32 Europe Global Sepsis Treatment Market Size, by Test Type, 2018 - 2023 (USD Billion)
Table 33 Europe Global Sepsis Treatment Market Size, by Test Type, 2025 - 2030 (USD Billion)
Table 34 Europe Global Sepsis Treatment Market Size, by End User, 2018 - 2023 (USD Billion)
Table 35 Europe Global Sepsis Treatment Market Size, by End User, 2025 - 2030 (USD Billion)
Table 36 Europe Global Sepsis Treatment Market Size, by Region, 2018 - 2023 (USD Billion)
Table 37 Europe Global Sepsis Treatment Market Size, by Region, 2025 - 2030 (USD Billion)
Table 38 Asia-Pacific Global Sepsis Treatment Market Size, by Technology Type,2018 - 2023 (USD Billion) Sepsis Treatment
Table 39 Asia-Pacific Global Sepsis Treatment Market Size, by Technology Type, 2025 - 2030 (USD Billion)
Table 40 Asia-Pacific Global Sepsis Treatment Market Size, by Product Type, 2018 - 2023 (USD Billion)
Table 41 Asia-Pacific Global Sepsis Treatment Market Size, by Product Type, 2025 - 2030 (USD Billion)
Table 42 Asia-Pacific Global Sepsis Treatment Market Size, by Pathogen, 2018 - 2023 (USD Billion)
Table 43 Asia-Pacific Global Sepsis Treatment Market Size, by Pathogen, 2025 - 2030 (USD Billion)
Table 44 Asia-Pacific Global Sepsis Treatment Market Size, by Test Type, 2018 - 2023 (USD Billion)
Table 45 Asia-Pacific Global Sepsis Treatment Market Size, by Test Type, 2025 - 2030 (USD Billion)
Table 46 Asia-Pacific Global Sepsis Treatment Market Size, by End User, 2018 - 2023 (USD Billion)
Table 47 Asia-Pacific Global Sepsis Treatment Market Size, by End User, 2025 - 2030 (USD Billion)
Table 48 Asia-Pacific Global Sepsis Treatment Market Size, by Region, 2018 - 2023 (USD Billion)
Table 49 Asia-Pacific Global Sepsis Treatment Market Size, by Region, 2025 - 2030 (USD Billion)
Table 50 RoW Global Sepsis Treatment Market Size, by Technology Type, 2018 - 2023 (USD Billion) Sepsis Treatment
Table 51 RoW Global Sepsis Treatment Market Size, by Technology Type, 2025 - 2030 (USD Billion)
Table 52 RoW Global Sepsis Treatment Market Size, by Product Type, 2018 - 2023 (USD Billion)
Table 53 RoW Global Sepsis Treatment Market Size, by Product Type, 2025 - 2030 (USD Billion)
Table 54 RoW Global Sepsis Treatment Market Size, by Pathogen, 2018 - 2023 (USD Billion)
Table 55 RoW Global Sepsis Treatment Market Size, by Pathogen, 2025 - 2030 (USD Billion)
Table 56 RoW Global Sepsis Treatment Market Size, by Test Type, 2018 - 2023 (USD Billion)
Table 57 RoW Global Sepsis Treatment Market Size, by Test Type, 2025 - 2030 (USD Billion)
Table 58 RoW Global Sepsis Treatment Market Size, by End User, 2018 - 2023 (USD Billion)
Table 59 RoW Global Sepsis Treatment Market Size, by End User, 2025 - 2030 (USD Billion)
Table 60 RoW Global Sepsis Treatment Market Size, by Region, 2018 - 2023 (USD Billion)
Table 61 RoW Global Sepsis Treatment Market Size, by Region, 2025 - 2030 (USD Billion)
Table 62 Snapshot–Abbott
Table 63 Snapshot–Pfizer Inc
Table 64 Snapshot–GlaxoSmithKline plc
Table 65 Snapshot–Bristol-Myers Squibb Company
Table 66 Snapshot–Adrenomed AG
Table 67 Snapshot–AM-Pharma B.V. 
Table 68 Snapshot–Johnson & Johnson
Table 69 Snapshot–Amomed Pharma GmbH
Table 70 Snapshot–Asahi Kasei Corporation
Table 71 Snapshot–Endacea, Inc
Table 72 Snapshot–Novartis
Table 73 Snapshot–TEVA
Table 74 Snapshot–INOTREM
Table 75 Snapshot–InflaRx N.V.
Table 76 Snapshot–Bayer 
Table 77 Snapshot–Shanghai Pharmaceuticals
Table 78 Snapshot–La Jolla Pharmaceutical Company
Table 79 Snapshot–TaiRx, Inc.

List of Figures

Figure 1 Market Coverage
Figure 2 Research Phases
Figure 3 Secondary Sources for Different Parameters
Figure 4 Methodology
Figure 5 Data Mining & Exploration
Figure 6 Data Triangulation
Figure 7 Assumptions for Market Estimation and Forecast
Figure 8 Market Synopsis
Figure 9 Global Sepsis Treatment Market - Growth Drivers and Restraints
Figure 10 Competitive Benchmark
Figure 11 Global Sepsis Treatment Market Highlight
Figure 12 Global Sepsis Treatment Market Size, by Technology Type, 2018 - 2030 (USD Billion)
Figure 13 Global Sepsis Treatment Market Size, by Product Type, 2018 - 2030 (USD Billion)
Figure 14 Global Sepsis Treatment Market Size, by Pathogen Type, 2018 - 2030 (USD Billion)
Figure 15 Global Sepsis Treatment Market Size, by Test Type, 2018 - 2030 (USD Billion)
Figure 16 Global Sepsis Treatment Market Size, by End User Type, 2018 - 2030 (USD Billion)
Figure 17 Global Sepsis Treatment Market Size, by Region, 2018 - 2030 (USD Billion)
Figure 18 North America Sepsis Treatment Market Highlight
Figure 19 North America Sepsis Treatment Market Size, by Technology Type, 2018 - 2030 (USD Billion)
Figure 20 North America Sepsis Treatment Market Size, by Product Type, 2018 - 2030 (USD Billion)
Figure 21 North America Sepsis Treatment Market Size, by Pathogen Type, 2018 - 2030 (USD Billion)
Figure 22 North America Sepsis Treatment Market Size, by Test Type, 2018 - 2030 (USD Billion)
Figure 23 North America Sepsis Treatment Market Size, by End User, 2018 - 2030 (USD Billion) 
Figure 24 North America Sepsis Treatment Market Size, by Region, 2018 - 2030 (USD Billion)
Figure 25 Europe Sepsis Treatment Market Highlight
Figure 26 Europe Sepsis Treatment Market Size, by Technology Type, 2018 - 2030 (USD Billion)
Figure 27 Europe Sepsis Treatment Market Size, by Product Type, 2018 - 2030 (USD Billion)
Figure 28 Europe Sepsis Treatment Market Size, by Pathogen Type, 2018 - 2030 (USD Billion)
Figure 29 Europe Sepsis Treatment Market Size, by Test Type, 2018 - 2030 (USD Billion)
Figure 30 Europe Sepsis Treatment Market Size, by End-User Type, 2018 - 2030 (USD Billion)
Figure 31 Europe Sepsis Treatment Market Size, by Region, 2018 - 2030 (USD Billion)
Figure 32 Asia-Pacific Sepsis Treatment Market Highlight
Figure 33 Asia-Pacific Sepsis Treatment Market Size, by Technology Type, 2018 - 2030 (USD Billion)
Figure 34 Asia-Pacific Sepsis Treatment Market Size, by Product Type, 2018 - 2030 (USD Billion)
Figure 35 Asia-Pacific Sepsis Treatment Market Size, by Pathogen Type,  2018 - 2030 (USD Billion)
Figure 36 Asia-Pacific Sepsis Treatment Market Size, by Test Type, 2018 - 2030 (USD Billion)
Figure 37 Asia-Pacific Sepsis Treatment Market Size, by End-User Type, 2018 - 2030 (USD Billion)
Figure 38 Asia-Pacific Sepsis Treatment Market Size, by Region, 2018 - 2030 (USD Billion)
Figure 39 RoW Sepsis Treatment Market Highlight
Figure 40 RoW Sepsis Treatment Market Size, by Technology Type, 2018 - 2030 (USD Billion)
Figure 41 RoW Sepsis Treatment Market Size, by Product Type, 2018 - 2030 (USD Billion)
Figure 42 RoW Sepsis Treatment Market Size, by Pathogen Type, 2018 - 2030 (USD Billion)
Figure 43 RoW Sepsis Treatment Market Size, by Test Type, 2018 - 2030 (USD Billion)
Figure 44 RoW Sepsis Treatment Market Size, by End-User Type, 2018 - 2030 (USD Billion)
Figure 45 RoW Sepsis Treatment Market Size, by Region, 2018 - 2030 (USD Billion)